A Polish baby came into the world under the influence of alcohol because his mother was drunk during labour, police said Friday.
Tests 12 hours after the boy's birth revealed a level of 1.2 grammes of alcohol per 1,000 grammes of blood - the equivalent of a bottle of wine or two litres of beer for an adult drinker.
In comparison, blood-alcohol limit for drivers in Poland is 0.2 grammes.
The baby was in intensive care on Friday, and although he was in a stable condition, doctors said they feared his brain could have suffered lasting damage.
Health & Wellness
An over reliance on technology is leading to a dumbing down of the nation's brain power, according a study published today.
In a society flooded with mobile phones, Blackberry devices and computers of various shapes and sizes, a quarter of all Britons do not know their own landline number while as little as a third can recall more than three birthdays of their immediate family.
In a society flooded with mobile phones, Blackberry devices and computers of various shapes and sizes, a quarter of all Britons do not know their own landline number while as little as a third can recall more than three birthdays of their immediate family.
Is a staple of healthy diets in America making us sick?
Consumers often abandon products when other social groups adopt them. Teens want to distinguish themselves from their parents. Jocks want to separate themselves from geeks. Rich Brits stopped buying Burberry once it became the brand of choice for soccer hooligans and Shanghai urbanites avoid the Volkswagen model that is preferred by the suburban nouveau riche. Yet, the same teens who wouldn't be caught dead wearing the same jeans as their parents have no problem using the same brand of detergent. A new study by Stanford researchers explores why some products are used by people to differentiate themselves from certain social groups.
"Prior work on individual drives for differentiation tells us a lot about who is more likely to prefer unique products or when people might be more likely to prefer them," write Jonah Berger and Chip Heath (Stanford University) in the August issue of the Journal of Consumer Research. "But these approaches have less to say about where people diverge, or why people diverge more in certain domains."
"Prior work on individual drives for differentiation tells us a lot about who is more likely to prefer unique products or when people might be more likely to prefer them," write Jonah Berger and Chip Heath (Stanford University) in the August issue of the Journal of Consumer Research. "But these approaches have less to say about where people diverge, or why people diverge more in certain domains."
Selenium, an antioxidant included in multivitamin tablets thought to have a possible protective effect against the development of type 2 diabetes, may actually increase the risk of developing the disease, an analysis by researchers at the University at Buffalo has shown.
Results of a randomized clinical trial using 200 micrograms of selenium alone showed that 55 percent more cases of type 2 diabetes developed among participants randomized to receive selenium than in those who received a placebo pill.
Results of a randomized clinical trial using 200 micrograms of selenium alone showed that 55 percent more cases of type 2 diabetes developed among participants randomized to receive selenium than in those who received a placebo pill.
The number of moles may offer an indication of how quickly the body ages, a study suggests.
King's College London scientists compared key ageing DNA with the number of moles in a study of 1,800 twins.
They found the more moles a person had, the more likely their DNA was to have the properties to fight off ageing.
The study, in the Cancer Epidemiology Biomarkers and Prevention journal, contrasts with the link between a high mole-count and high skin cancer risk.
Moles appear in childhood and disappear from middle age onwards.
When present in large numbers they can increase the risk of melanoma, a rare form of skin cancer. Moles vary significantly in numbers and size between individuals.
King's College London scientists compared key ageing DNA with the number of moles in a study of 1,800 twins.
They found the more moles a person had, the more likely their DNA was to have the properties to fight off ageing.
The study, in the Cancer Epidemiology Biomarkers and Prevention journal, contrasts with the link between a high mole-count and high skin cancer risk.
Moles appear in childhood and disappear from middle age onwards.
When present in large numbers they can increase the risk of melanoma, a rare form of skin cancer. Moles vary significantly in numbers and size between individuals.
Fake Sensodyne toothpaste which contains traces of toxic chemicals is being sold in markets, discount shops and car boot sales, the UK's medicines watchdog warned today.
The contaminated 50ml tubes of Sensodyne Original and Sensodyne Mint contain potentially dangerous levels of diethylene glycol, which could harm anyone with an impaired liver or kidney function and young children.
The Medicines and Healthcare Products Regulatory Agency (MHRA) warned that the fake products were being made by "unauthorised" copycat suppliers who printed their tubes in both English and Arabic, with genuine Sensodyne products only ever being printed in English.
The affected batch code is PROD 07 2005/EXP 08/2008, the agency said, instructing anyone who believes they may have bought the product to throw all tubes away.
The contaminated 50ml tubes of Sensodyne Original and Sensodyne Mint contain potentially dangerous levels of diethylene glycol, which could harm anyone with an impaired liver or kidney function and young children.
Comment: And what about similar harm effects of Fluoride? Why doesn't the UK's medicines watchdog warn the public about THAT?
The Medicines and Healthcare Products Regulatory Agency (MHRA) warned that the fake products were being made by "unauthorised" copycat suppliers who printed their tubes in both English and Arabic, with genuine Sensodyne products only ever being printed in English.
Comment:
Oh, we get it. If it's printed in Arabic, it's Eeeevil! Those damn terrorists are everywhere, and they are going to poison us!
Oh, we get it. If it's printed in Arabic, it's Eeeevil! Those damn terrorists are everywhere, and they are going to poison us!
The affected batch code is PROD 07 2005/EXP 08/2008, the agency said, instructing anyone who believes they may have bought the product to throw all tubes away.
Comment: Along with those tubes don't forget to throw a way last remains of common sense.
In the month after a surprising analysis revealed possible heart risks from the blockbuster diabetes drug Avandia, reports of side effects to federal regulators tripled.
WASHINGTON - The business of developing and selling new drugs is fraught with peril and setbacks. Billions of dollars are at stake. Nerves are on edge. Tempers flare.
Just ask Dr. John B. Buse, a medical researcher who testified at a House hearing on Wednesday about the safety of the popular diabetes drug, Avandia.
Just ask Dr. John B. Buse, a medical researcher who testified at a House hearing on Wednesday about the safety of the popular diabetes drug, Avandia.
An article in a leading medical journal yesterday raised serious safety questions about the widely used diabetes pill Avandia and renewed skepticism about the vigilance of federal drug regulators.
The analysis, based on a review of more than 40 existing clinical studies involving nearly 28,000 patients, showed that Avandia significantly increased the risk of heart attacks, compared with other diabetes drugs or a placebo.
Both the study's lead author and the editors of The New England Journal of Medicine, in which the article appeared, cautioned that the research method used left the findings open to interpretation. But they said the study nevertheless raised important concerns.
And the publication of the study on the journal's Web site prompted the Food and Drug Administration to issue a public safety alert and advise users of the drug - an estimated million people in this country and two million worldwide - to consult their doctors about the potential cardiovascular risks.
The analysis, based on a review of more than 40 existing clinical studies involving nearly 28,000 patients, showed that Avandia significantly increased the risk of heart attacks, compared with other diabetes drugs or a placebo.
Both the study's lead author and the editors of The New England Journal of Medicine, in which the article appeared, cautioned that the research method used left the findings open to interpretation. But they said the study nevertheless raised important concerns.
And the publication of the study on the journal's Web site prompted the Food and Drug Administration to issue a public safety alert and advise users of the drug - an estimated million people in this country and two million worldwide - to consult their doctors about the potential cardiovascular risks.
Comment: You may want to follow a discussion on this subject on our Forum:
Fasting, Gluten, MSG, Soy, Blood Type Diet